Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Diagnosis Drift and Its Contribution to Polypharmacy.

Reidenberg MM.

Clin Pharmacol Ther. 2018 Apr;103(4):556-557. doi: 10.1002/cpt.858. Epub 2017 Oct 3.

PMID:
28971479
2.

Are we moving towards a new definition of essential medicines?

Reidenberg MM.

J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):233. doi: 10.4103/0976-500X.171874. No abstract available.

3.

Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia.

Tjia J, Reidenberg MM, Hunnicutt JN, Paice K, Donovan JL, Kanaan A, Briesacher BA, Lapane KL.

Consult Pharm. 2015 Oct;30(10):599-611. doi: 10.4140/TCP.n.2015.599. Review.

PMID:
26450142
4.

Statins for Primary Prevention in Adults Aged 75 Years or Older.

Reidenberg MM.

Ann Intern Med. 2015 Sep 15;163(6):481. doi: 10.7326/L15-5135-2. No abstract available.

PMID:
26370014
5.

Should administration of coenzyme Q10 be recommended to patients with congestive heart failure?

Reidenberg MM.

Clin Pharmacol Ther. 2014 Dec;96(6):647-9. doi: 10.1038/clpt.2014.166. No abstract available.

PMID:
25399711
6.

Lack of transparency in emergency care.

Reidenberg MM.

Ann Intern Med. 2013 Dec 17;159(12):857. doi: 10.7326/0003-4819-159-12-201312170-00017. No abstract available.

PMID:
24343398
7.

Vitamin D and calcium supplementation to prevent fractures in adults.

Reidenberg MM.

Ann Intern Med. 2013 Dec 17;159(12):856. doi: 10.7326/0003-4819-159-12-201312170-00015. No abstract available.

PMID:
24343397
8.

Alzheimer's disease and Down's syndrome: treating two paths to dementia.

Weksler ME, Szabo P, Relkin NR, Reidenberg MM, Weksler BB, Coppus AM.

Autoimmun Rev. 2013 Apr;12(6):670-3. doi: 10.1016/j.autrev.2012.10.013. Epub 2012 Nov 29. Review.

PMID:
23201920
9.

U.S. basic research: delayed drug development.

Reidenberg MM, Erle H.

Science. 2012 Sep 28;337(6102):1605. No abstract available.

PMID:
23019629
10.

Cigarette smoking, coffee drinking, and ingestion of charcoal-broiled beef as potential modifiers of drug therapy and confounders of clinical trials.

Conney AH, Reidenberg MM.

J Pharmacol Exp Ther. 2012 Jul;342(1):9-14. doi: 10.1124/jpet.112.193193. Epub 2012 Apr 18.

PMID:
22514335
11.

Early research on renal function and drug action.

Reidenberg MM.

J Clin Pharmacol. 2012 Jan;52(1 Suppl):7S-9S. doi: 10.1177/0091270011413587.

12.

Drug discontinuation effects are part of the pharmacology of a drug.

Reidenberg MM.

J Pharmacol Exp Ther. 2011 Nov;339(2):324-8. doi: 10.1124/jpet.111.183285. Epub 2011 Aug 17.

13.

Use of opioids in management of chronic noncancer pain.

Reidenberg MM.

Ann Intern Med. 2010 Jun 1;152(11):757; author reply 757-8. doi: 10.7326/0003-4819-152-11-201006010-00024. No abstract available.

PMID:
20513842
14.

From adverse drug reactions to drug disposition to WHO and essential medicines to our discipline of clinical pharmacology.

Reidenberg MM.

Clin Pharmacol Ther. 2010 Feb;87(2):163-5. doi: 10.1038/clpt.2009.49. No abstract available.

PMID:
20107452
15.

Can the selection and use of essential medicines decrease inappropriate drug use?

Reidenberg MM.

Clin Pharmacol Ther. 2009 Jun;85(6):581-3. doi: 10.1038/clpt.2009.10.

PMID:
19451911
16.

A new look at the profession of clinical pharmacology.

Reidenberg MM.

Clin Pharmacol Ther. 2008 Feb;83(2):213-7. doi: 10.1038/sj.clpt.6100424.

PMID:
18202686
17.

Essential medicines for the whole world.

Reidenberg MM.

Clin Pharmacol Ther. 2007 Nov;82(5):500-3.

PMID:
17952105
18.

Physicians being deceived.

Jung B, Reidenberg MM.

Pain Med. 2007 Jul-Aug;8(5):433-7.

PMID:
17661857
19.

Benefit/risk ratio of statins in primary prevention.

Reidenberg MM.

Clin Pharmacol Ther. 2008 Mar;83(3):498-500. Epub 2007 May 30. Review. No abstract available.

PMID:
17538549
20.

Statins for primary prevention of coronary artery disease.

Reidenberg MM.

Lancet. 2007 Mar 31;369(9567):1078; author reply 1079. No abstract available.

PMID:
17398297
21.

Prosecution of physicians for prescribing opioids to patients.

Reidenberg MM, Willis O.

Clin Pharmacol Ther. 2007 Jun;81(6):903-6. Epub 2007 Feb 28.

PMID:
17329989
22.

World Health Organization program for the selection and use of essential medicines.

Reidenberg MM.

Clin Pharmacol Ther. 2007 Apr;81(4):603-6. Epub 2007 Feb 21.

PMID:
17314928
23.

Are drugs for rare diseases "essential"?

Reidenberg MM.

Bull World Health Organ. 2006 Sep;84(9):686. No abstract available.

24.
25.

Improving how we evaluate the toxicity of approved drugs.

Reidenberg MM.

Clin Pharmacol Ther. 2006 Jul;80(1):1-6. Epub 2006 Jun 8. Review. No abstract available.

PMID:
16815311
26.

Clinical trials report card.

Reidenberg MM.

N Engl J Med. 2006 Mar 30;354(13):1426-9; author reply 1426-9. No abstract available.

PMID:
16575951
27.

Informed consent or acknowledgment of disclosure.

Reidenberg MM.

Clin Pharmacol Ther. 2005 Oct;78(4):439-40. No abstract available.

PMID:
16198663
28.

Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies.

Jung BF, Reidenberg MM.

Clin Pharmacol Ther. 2005 Apr;77(4):324-34. Review. No abstract available. Erratum in: Clin Pharmacol Ther. 2006 May;79(5):510. Dosage error in article text.

PMID:
15903130
29.

Statins, lack of energy and ubiquinone.

Reidenberg MM.

Br J Clin Pharmacol. 2005 May;59(5):606-7. No abstract available.

30.

The risk of disciplinary action by state medical boards against physicians prescribing opioids.

Richard J, Reidenberg MM.

J Pain Symptom Manage. 2005 Feb;29(2):206-12.

31.

Issues in developing the medical scientist, Part 3: Evaluation of scientific achievement (essay by and interview with Marcus M. Reidenberg, MD).

Reidenberg MM.

J Investig Med. 2004 Sep;52(6):361-3. doi: 10.1136/jim-52-06-28. Review. No abstract available.

PMID:
15612447
32.

The pros and cons of essential medicines for rich countries.

Reidenberg MM, Walley T.

BMJ. 2004 Nov 13;329(7475):1172. No abstract available.

34.

Evolving ways that drug therapy is individualized.

Reidenberg MM.

Clin Pharmacol Ther. 2003 Sep;74(3):197-202. Review. No abstract available.

PMID:
12966363
35.

Rational prescribing of essential medicines.

Reidenberg MM.

Clin Pharmacol Ther. 2003 Aug;74(2):195. No abstract available.

PMID:
12891230
36.

What has been the impact of the concept of essential drugs?

Levy M, Reidenberg MM.

Clin Pharmacol Ther. 2003 Apr;73(4):275-8. Review. No abstract available.

PMID:
12709716
37.

Drug labeling should be kept current.

Rajpal A, Reidenberg MM.

Clin Pharmacol Ther. 2003 Jan;73(1):4-6. No abstract available.

PMID:
12545138
38.

Conflict of interest and medical publication.

Reidenberg MM.

Sci Eng Ethics. 2002 Jul;8(3):455-7.

PMID:
12353375
39.

Different pathways of cell killing by gossypol enantiomers.

Qiu J, Levin LR, Buck J, Reidenberg MM.

Exp Biol Med (Maywood). 2002 Jun;227(6):398-401.

PMID:
12037129
40.

Who should have access to the research data?

Reidenberg MM, Reidenberg JW.

Clin Pharmacol Ther. 2002 May;71(5):309-10. No abstract available.

PMID:
12011816
41.
42.

Sponsorship, authorship and accountability.

Reidenberg MM.

N Z Med J. 2001 Dec 14;114(1145):558; author reply 559. No abstract available.

PMID:
11833960
43.

Sponsorship, authorship, and accountability.

Reidenberg MM.

N Engl J Med. 2002 Jan 24;346(4):290-2. No abstract available.

PMID:
11808615
44.

Clinical Pharmacology & Therapeutics Annual report 2000.

Reidenberg MM, Reidenberg J.

Clin Pharmacol Ther. 2001 Sep;70(3):299-301. No abstract available.

PMID:
11557919
45.

An open invitation for an explanation about how drug prices are set.

Reidenberg MM.

Clin Pharmacol Ther. 2001 Sep;70(3):205-7. No abstract available.

PMID:
11557906
46.

Releasing the grip of big pharma.

Reidenberg MM.

Lancet. 2001 Aug 25;358(9282):664. No abstract available.

PMID:
11545072
47.

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.

Van Poznak C, Seidman AD, Reidenberg MM, Moasser MM, Sklarin N, Van Zee K, Borgen P, Gollub M, Bacotti D, Yao TJ, Bloch R, Ligueros M, Sonenberg M, Norton L, Hudis C.

Breast Cancer Res Treat. 2001 Apr;66(3):239-48.

PMID:
11510695
48.

Counterfeit and substandard drugs.

Reidenberg MM, Conner BA.

Clin Pharmacol Ther. 2001 Apr;69(4):189-93. No abstract available.

PMID:
11309546
49.

Centers for education and research in therapeutics.

Reidenberg MM.

Clin Pharmacol Ther. 2000 Aug;68(2):109-10. No abstract available.

PMID:
10976540
50.

Environmental inhibition of 11beta-hydroxysteroid dehydrogenase.

Reidenberg MM.

Toxicology. 2000 Apr 3;144(1-3):107-11. Review.

PMID:
10781877

Supplemental Content

Loading ...
Support Center